{"id":209177,"name":"BOEHRINGER INGELHEIM USA CORPORATION","slug":"boehringer-ingelheim-usa-corporation","state":"CT","country":"United States of America","description":"Pharmaceutical company","totalSpending":970000,"filings":21,"yearlySpending":[{"year":2021,"income":170000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":200000}],"issues":[{"code":"AGR","display":"Agriculture"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"DEF","display":"Defense"}],"firms":["MONUMENT ADVOCACY"],"lobbyists":["THOMAS HAWKS","LILIA HORDER","POORVIE BISHNOI","JOHN WEBER"],"govEntities":["Agriculture, Dept of (USDA)","HOUSE OF REPRESENTATIVES","SENATE","Environmental Protection Agency (EPA)","Food & Drug Administration (FDA)"],"sampleDescriptions":["Issues related to general agriculture issues, animal health, regulatory processes, COVID-19, appropriations","Issues related to general agriculture issues, animal health, regulatory processes, COVID-19, appropriations","Issues related to general agriculture issues; animal health; regulatory processes; COVID-19","Issues related to FY 2022 appropriations","National Defense Authorization Act; Issues related to animal health"]}